Los Angeles Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.5M | Sell |
246,585
-1,565,149
| -86% | -$109M | 0.06% | 209 |
|
|
2025
Q4 | $124M | Buy |
1,811,734
+191,330
| +12% | +$12.4M | 0.42% | 47 |
|
|
2025
Q3 | $109M | Buy |
1,620,404
+323,590
| +25% | +$25.6M | 0.37% | 52 |
|
|
2025
Q2 | $113M | Buy |
1,296,814
+983,018
| +313% | +$77.1M | 0.42% | 46 |
|
|
2025
Q1 | $21.4M | Buy |
313,796
+232,705
| +287% | +$19M | 0.09% | 159 |
|
|
2024
Q4 | $6.31M | Buy |
81,091
+74,360
| +1,105% | +$5.51M | 0.03% | 298 |
|
|
2024
Q3 | $451K | Sell |
6,731
-28,485
| -81% | -$2.34M | ﹤0.01% | 888 |
|
|
2024
Q2 | $3.99M | Sell |
35,216
-321,817
| -90% | -$40.7M | 0.01% | 355 |
|
|
2024
Q1 | $49.5M | Buy |
357,033
+137,336
| +63% | +$17.3M | 0.17% | 125 |
|
|
2023
Q4 | $27.3M | Sell |
219,697
-73,643
| -25% | -$7.52M | 0.1% | 174 |
|
|
2023
Q3 | $27.4M | Sell |
293,340
-725,820
| -71% | -$81.8M | 0.12% | 164 |
|
|
2023
Q2 | $131M | Buy |
1,019,160
+331,983
| +48% | +$40.2M | 0.53% | 40 |
|
|
2023
Q1 | $79.8M | Buy |
687,177
+574,273
| +509% | +$64.3M | 0.35% | 69 |
|
|
2022
Q4 | $12.8M | Buy |
112,904
+74,120
| +191% | +$8.14M | 0.06% | 243 |
|
|
2022
Q3 | $3.12M | Buy |
38,784
+20,328
| +110% | +$1.72M | 0.02% | 432 |
|
|
2022
Q2 | $1.38M | Buy |
18,456
+10,124
| +122% | +$924K | 0.01% | 626 |
|
|
2022
Q1 | $1.07M | Buy |
8,332
+5,048
| +154% | +$552K | ﹤0.01% | 730 |
|
|
2021
Q4 | $441K | Buy |
3,284
+1,240
| +61% | +$178K | ﹤0.01% | 1068 |
|
|
2021
Q3 | $279K | Sell |
2,044
-7,072
| -78% | -$892K | ﹤0.01% | 1333 |
|
|
2021
Q2 | $973K | Sell |
9,116
-430,156
| -98% | -$41.3M | ﹤0.01% | 874 |
|
|
2021
Q1 | $39.5M | Sell |
439,272
-205,780
| -32% | -$19.3M | 0.18% | 126 |
|
|
2020
Q4 | $59.6M | Sell |
645,052
-15,240
| -2% | -$1.36M | 0.25% | 88 |
|
|
2020
Q3 | $68M | Buy |
660,292
+104,020
| +19% | +$10.9M | 0.31% | 72 |
|
|
2020
Q2 | $56.4M | Buy |
556,272
+98,396
| +21% | +$8.8M | 0.27% | 89 |
|
|
2020
Q1 | $30.8M | Buy |
457,876
+93,240
| +26% | +$5.8M | 0.2% | 113 |
|
|
2019
Q4 | $19.9M | Buy |
364,636
+100,236
| +38% | +$4.75M | 0.1% | 190 |
|
|
2019
Q3 | $9.87M | Sell |
264,400
-22,640
| -8% | -$880K | 0.05% | 281 |
|
|
2019
Q2 | $10.8M | Sell |
287,040
-110,184
| -28% | -$3.46M | 0.06% | 290 |
|
|
2019
Q1 | $11.8M | Sell |
397,224
-304,480
| -43% | -$10.7M | 0.07% | 283 |
|
|
2018
Q4 | $21M | Sell |
701,704
-153,688
| -18% | -$4.88M | 0.13% | 175 |
|
|
2018
Q3 | $30.6M | Buy |
855,392
+45,560
| +6% | +$1.41M | 0.16% | 160 |
|
|
2018
Q2 | $19.2M | Buy |
+809,832
| New | +$17.2M | 0.11% | 235 |
|
|
2016
Q1 | – | Sell |
-86,020
| Closed | -$1.76M | – | 1148 |
|
|
2015
Q4 | $1.76M | Sell |
86,020
-30,580
| -26% | -$636K | 0.02% | 536 |
|
|
2015
Q3 | $2.5M | Buy |
116,600
+840
| +0.7% | +$18.7K | 0.02% | 493 |
|
|
2015
Q2 | $2.31M | Buy |
115,760
+27,292
| +31% | +$479K | 0.02% | 539 |
|
|
2015
Q1 | $1.38M | Buy |
88,468
+11,644
| +15% | +$176K | 0.01% | 660 |
|
|
2014
Q4 | $1.06M | Buy |
+76,824
| New | +$941K | 0.01% | 647 |
|
Other funds holding DXCM
VCM
VPM
Los Angeles Capital Management's DXCM Position: Q1 2026 in Review
Los Angeles Capital Management reduced its DexCom (DXCM) stake by 86% in Q1 2026, selling an estimated $109M and leaving 246,585 shares worth $15.5M. The position accounts for 0.06% of the portfolio, ranked #209.
Los Angeles Capital Management first reported a position in DXCM in Q4 2014 and has held it in 37 quarters since. The position peaked at $131M in Q2 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Los Angeles Capital Management held 246,585 shares of DexCom worth $15.5M as of Q1 2026.
- Los Angeles Capital Management sold 1,565,149 DexCom shares in Q1 2026, an estimated $109M.
- DexCom made up 0.06% of Los Angeles Capital Management's portfolio in Q1 2026, its #209 holding.
- Los Angeles Capital Management first reported a position in DexCom in Q4 2014 and has held it in 37 quarters since.
- Los Angeles Capital Management's DexCom position peaked at $131M in Q2 2023.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.